International Patent: GENE EDITING SYSTEM TARGETING HYDROXYACID OXIDASE 1 (HAO1) AND USES THEREOF FOR TREATING PRIMARY HYPEROXALURIA 1 (PH1)

GENEVA, Aug. 31 -- ARBOR BIOTECHNOLOGIES, INC. filed a patent application (IB2026/051538) for “GENE EDITING SYSTEM TARGETING HYDROXYACID OXIDASE 1 (HAO1) AND USES THEREOF FOR TREATING PRIMARY HYPEROXALURIA 1 (PH1)”. With publication no. WO/2026/176324, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 48/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....